阿尔茨海默病(AD)是老年期常见的一类慢性、进行性神经细胞退行性病变。应用毒蕈碱M1受体激动剂是治疗AD的策略之一。M1受体激动剂可通过对抗淀粉样β蛋白产生的神经毒性,减少tau蛋白的过度磷酸化,产生神经生长因子样作用,以及缩短后超极化时程等机制而产生神经保护作用。
Alzheimer's disease (AD) is a chronic, progressive neurodegenerative disease. Using M1 agonsits is one of the effective strategies for AD. M1 agonists may result in neuroprotective effects via attenuating of amyloid β-protein (Aβ) neurotoxicity, reducing tau-protein hyperphosphorylation, forming growth factor-like effects and reducing afterhyperpolarization(AHP).